The palliative role of lasers in the treatment of melanoma
Open Access
- 25 May 2024
- journal article
- review article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (6) , 1-11
Abstract
Melanoma, accounting for a significant proportion of skin cancer-related deaths, has variable survival outcomes based on the stage at diagnosis and treatment efficacy. Traditional treatments, while effective, pose risks of scarring and systemic side effects. Laser therapy offers an emerging non-surgical alternative, with CO2 lasers particularly showing promise in palliative care.A comprehensive search was conducted using PubMed, focusing on laser therapy for melanoma treatment. The search included studies on both stand-alone and adjunct laser therapies, with inclusion criteria requiring peer-reviewed articles detailing treatment outcomes for primary, recurrent, or metastatic melanoma.The literature shows that laser therapy for melanoma falls into four major types when categorized by laser medium: solid-state, diode, pulse-dye, and gas (CO2). Data on solid-state lasers for melanoma are limited and their use remains controversial. However, one study with high-energy pulsed neodymium lasers reported a 5-year survival of 82.9% with minimal adverse effects for primary melanoma. CO2 laser therapy has been effective for palliative treatment, with one study showing 54.8% of patients with recurrent melanoma surviving 5.4 years post-ablation. For metastatic melanoma, numerous studies have shown that CO2 laser therapy can provide symptomatic relief and disease control. Combination therapies using lasers and immune-based therapies have demonstrated enhanced outcomes and immune activation, highlighting the potential of laser therapies in melanoma management.While traditional treatments remain the standard for primary melanoma, laser therapies, particularly CO2 laser ablation, show substantial promise in palliative care for metastatic melanoma. Careful patient selection and assessment are crucial for achieving positive outcomes.Keywords
This publication has 33 references indexed in Scilit:
- Melanoma after laser therapy of pigmented lesions – circumstances and outcomeEuropean Journal Of Dermatology, 2010
- Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastasesLasers in Medical Science, 2008
- Progression of lentigo maligna into lentigo maligna melanoma following laser treatment.2007
- Metastasis of a Malignant Melanoma 2 Years after Carbon Dioxide Laser Treatment of a Pigmented Lesion: Case Report and Review of the LiteratureActa Dermato-Venereologica, 2005
- Treatment of cutaneous metastatic melanoma with imiquimod 5% cream and the pulsed-dye laserBritish Journal of Dermatology, 2005
- Ten-year experience of carbon dioxide laser ablation as treatment for cutaneous recurrence of malignant melanomaBritish Journal of Surgery, 2004
- Malignant melanoma occurring at the periphery of a giant congenital naevus previously treated with laser therapyBritish Journal of Dermatology, 2003
- In vitro study examining the effect of sub‐lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell linesLasers in Surgery and Medicine, 2003
- Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanomaBritish Journal of Surgery, 1996
- Carbon dioxide laser ablation as an alternative treatment for cutaneous metastases from malignant melanomaBritish Journal of Surgery, 1995